Lunesta and Dermatitis atopic aggravated - a phase IV clinical study of FDA data

Summary:

Dermatitis atopic aggravated is reported as a side effect among people who take Lunesta (eszopiclone), especially for people who are female, 30-39 old, also take Dupixent, and have Musculoskeletal stiffness.

The phase IV clinical study analyzes which people have Dermatitis atopic aggravated when taking Lunesta. It is created by eHealthMe based on reports of 25,141 people who have side effects when taking Lunesta from the FDA, and is updated regularly.

What is Lunesta?

Lunesta has active ingredients of eszopiclone. It is often used in insomnia. eHealthMe is studying from 26,936 Lunesta users. Check the latest studies of Lunesta.

What is Dermatitis atopic aggravated?

Dermatitis atopic aggravated (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder) is found to be associated with 612 drugs and 179 conditions by eHealthMe. Check the latest studies of Dermatitis atopic aggravated.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

25,141 people reported to have side effects when taking Lunesta.
Among them, 17 people (0.07%) have Dermatitis atopic aggravated.

Could Lunesta cause Dermatitis atopic aggravated?

Among these 17 people:

What is the gender of people who have Dermatitis atopic aggravated when taking Lunesta? *

female: 88.24 %
male: 11.76 %

What is the age of people who have Dermatitis atopic aggravated when taking Lunesta? *

What are other drugs people take besides Lunesta? *

What are other side effects people have besides Dermatitis atopic aggravated? *

Rashes (redness): 13 people, 76.47%
Discomfort: 6 people, 35.29%
Visual Field Defect: 5 people, 29.41%
Conjunctivitis Allergic (inflammation of the conjunctiva due to allergy): 5 people, 29.41%
Constipation: 5 people, 29.41%
Diarrhea: 5 people, 29.41%
High Blood Pressure: 5 people, 29.41%
Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 5 people, 29.41%
Nasopharyngitis (inflammation of the nasopharynx): 5 people, 29.41%
Mental Impairment (a condition affecting the body, perhaps through sight or hearing loss, a mobility difficulty or a health condition): 5 people, 29.41%

What are the existing conditions these people have? *

Visual Field Defect: 5 people, 29.41%
Lupus Nephritis (a chronic inflammatory autoimmune disorder that may affect kidney tissue): 5 people, 29.41%
Conjunctivitis Allergic (inflammation of the conjunctiva due to allergy): 5 people, 29.41%
Constipation: 5 people, 29.41%
Diarrhea: 5 people, 29.41%
Gastritis (inflammation of stomach): 5 people, 29.41%
High Blood Pressure: 5 people, 29.41%
Iron Deficiency Anaemia: 5 people, 29.41%
Mental Impairment (a condition affecting the body, perhaps through sight or hearing loss, a mobility difficulty or a health condition): 5 people, 29.41%
Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 5 people, 29.41%

* Approximation only. Some reports may have incomplete information.

Do you take Lunesta and have Dermatitis atopic aggravated?

- Check whether Dermatitis atopic aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lunesta:

Lunesta (26,936 reports)

Browse all side effects of Lunesta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dermatitis atopic aggravated:

Dermatitis atopic aggravated (612 drugs)

Browse all the conditions that are associated with Dermatitis atopic aggravated:

Dermatitis atopic aggravated (179 conditions)

Related publications that referenced our studies

Lai SW, Lai HC, Lin CL, Liao KF, "Zopiclone use associated with increased risk of acute pancreatitis: a case–control study in Taiwan", International journal of clinical practice, 2015 Nov .
Lai SW, Lai HC, Lin CL, Liao KF, "Zopiclone use associated with increased risk of acute pancreatitis: a case–control study in Taiwan", International journal of clinical practice, 2015 Nov .

How the study uses the data?

The study uses data from the FDA. It is based on eszopiclone (the active ingredients of Lunesta) and Lunesta (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.